2025
SJR Q3
JCR Q2 · 1,7
2 matched articles
SSCI
Journal detail
Theoretical Medicine and Bioethics
- Publisher
- Springer Science and Business Media B.V.
- Country
- Netherlands · Western Europe
- Type
- journal
- ISSN
-
1386741515731200
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,373
- Quartile Q3
- H-Index 47
- Cites/doc 1,39
- Docs (3y) 98
- Cites (3y) 135
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 1,7
- 5Y JIF 1,5
- JCI 0,58
WoS indexes
- SSCI
Subject classification
Categories (SJR)
- Issues, Ethics and Legal Aspects Q3
- Medicine (miscellaneous) Q3
Areas
- Medicine
- Nursing
WoS categories
- Ethics | Social Issues | Social Sciences, Biomedical
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q3 | Q2 | 0,373 | 1,7 | 1,5 | 0,58 | Q3 | 47 |
| 2024 | Q3 | Q2 | 0,345 | 1,5 | 1,7 | 0,63 | Q3 | 46 |
| 2023 | Q4 | Q3 | 0,188 | 1,1 | 1,3 | 0,55 | Q3 | 46 |
| 2022 | Q2 | Q3 | 0,46 | 1,4 | 1,6 | 0,78 | Q2 | 46 |
| 2021 | Q2 | Q2 | 0,463 | 2,2 | 1,5 | 0,6 | Q3 | 46 |
| 2020 | Q3 | Q4 | 0,366 | 0,9 | 1,4 | 0,64 | Q3 | 46 |
| 2019 | Q3 | Q3 | 0,339 | 0,9 | 1,1 | 0,58 | Q3 | 46 |
| 2018 | — | Q3 | — | 0,8 | 1 | 0,68 | Q3 | — |
| 2017 | Q2 | Q3 | 0,377 | 0,6 | 1 | 0,64 | Q3 | 46 |
| 2016 | Q3 | Q3 | 0,305 | 0,7 | 0,8 | — | — | 46 |
| 2015 | Q2 | Q3 | 0,454 | 0,8 | 1 | — | — | 46 |
| 2014 | Q3 | Q3 | 0,367 | 0,5 | 0,8 | — | — | 46 |
| 2013 | Q2 | Q2 | 0,431 | 0,9 | 0,9 | — | — | 46 |
| 2012 | Q1 | Q2 | 0,601 | 1 | 0,9 | — | — | 46 |
| 2011 | Q1 | Q2 | 0,665 | 0,8 | 1,1 | — | — | 46 |
| 2010 | Q2 | Q3 | 0,353 | 0,5 | 0,7 | — | — | 46 |
| 2009 | — | Q2 | — | 0,7 | 1 | — | — | — |
| 2008 | — | Q2 | — | 0,7 | 0,8 | — | — | — |
| 2007 | — | Q2 | — | 0,6 | 0,7 | — | — | — |
| 2006 | — | Q2 | — | 0,6 | — | — | — | — |
| 2005 | — | Q2 | — | 0,8 | — | — | — | — |
| 2004 | — | Q3 | — | 0,4 | — | — | — | — |
| 2003 | — | Q3 | — | 0,3 | — | — | — | — |
| 2002 | — | Q3 | — | 0,3 | — | — | — | — |
| 2001 | — | Q2 | — | 0,4 | — | — | — | — |
| 2000 | — | Q2 | — | 0,4 | — | — | — | — |
| 1999 | — | Q3 | — | 0,2 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | ETHICS | SSCI | Q2 | Q3 | 33/78 |
| 2025 | SOCIAL ISSUES | SSCI | Q2 | Q3 | 36/72 |
| 2025 | SOCIAL SCIENCES, BIOMEDICAL | SSCI | Q3 | Q3 | 32/48 |
| 2024 | ETHICS | SSCI | Q2 | Q3 | 38/77 |
| 2024 | SOCIAL ISSUES | SSCI | Q3 | Q3 | 35/69 |
| 2024 | SOCIAL SCIENCES, BIOMEDICAL | SSCI | Q3 | Q3 | 32/48 |
| 2023 | ETHICS | SSCI | Q3 | Q3 | 46/77 |
| 2023 | SOCIAL ISSUES | SSCI | Q3 | Q3 | 36/67 |
| 2023 | SOCIAL SCIENCES, BIOMEDICAL | SSCI | Q4 | Q4 | 42/46 |
| 2022 | ETHICS | SSCI | Q3 | Q2 | 31/57 |
| 2022 | SOCIAL ISSUES | SSCI | Q3 | Q2 | 32/44 |
| 2022 | SOCIAL SCIENCES, BIOMEDICAL | SSCI | Q4 | Q3 | 40/45 |
| 2021 | ETHICS | SSCI | Q2 | Q3 | 22/56 |
| 2021 | SOCIAL ISSUES | SSCI | Q3 | Q3 | 27/44 |
| 2021 | SOCIAL SCIENCES, BIOMEDICAL | SSCI | Q3 | Q4 | 32/46 |
| 2020 | ETHICS | SSCI | Q4 | Q3 | 44/56 |
| 2020 | SOCIAL ISSUES | SSCI | Q4 | Q3 | 37/44 |
| 2020 | SOCIAL SCIENCES, BIOMEDICAL | SSCI | Q4 | Q4 | 40/44 |
| 2019 | ETHICS | SSCI | Q3 | Q3 | 32/55 |
| 2019 | SOCIAL ISSUES | SSCI | Q4 | Q3 | 34/44 |
| 2019 | SOCIAL SCIENCES, BIOMEDICAL | SSCI | Q4 | Q4 | 41/45 |
| 2018 | ETHICS | SSCI | Q3 | Q3 | 37/54 |
| 2018 | SOCIAL ISSUES | SSCI | Q4 | Q3 | 35/42 |
| 2018 | SOCIAL SCIENCES, BIOMEDICAL | SSCI | Q4 | Q3 | 40/45 |
| 2017 | ETHICS | SSCI | Q3 | Q3 | 36/52 |
| 2017 | SOCIAL ISSUES | SSCI | Q4 | Q3 | 33/40 |
| 2017 | SOCIAL SCIENCES, BIOMEDICAL | SSCI | Q4 | Q4 | 39/42 |
| 2016 | ETHICS | SSCI | Q3 | — | 35/51 |
| 2016 | SOCIAL ISSUES | SSCI | Q3 | — | 28/41 |
| 2016 | SOCIAL SCIENCES, BIOMEDICAL | SSCI | Q4 | — | 34/40 |
| 2015 | ETHICS | SSCI | Q3 | — | 30/51 |
| 2015 | SOCIAL ISSUES | SSCI | Q3 | — | 27/41 |
| 2015 | SOCIAL SCIENCES, BIOMEDICAL | SSCI | Q4 | — | 33/39 |
| 2014 | ETHICS | SSCI | Q3 | — | 32/52 |
| 2014 | SOCIAL ISSUES | SSCI | Q3 | — | 29/41 |
| 2014 | SOCIAL SCIENCES, BIOMEDICAL | SSCI | Q4 | — | 34/39 |
| 2013 | ETHICS | SSCI | Q2 | — | 21/50 |
| 2013 | SOCIAL ISSUES | SSCI | Q3 | — | 22/42 |
| 2013 | SOCIAL SCIENCES, BIOMEDICAL | SSCI | Q3 | — | 26/37 |
| 2012 | ETHICS | SSCI | Q2 | — | 17/48 |
| 2012 | SOCIAL ISSUES | SSCI | Q2 | — | 17/39 |
| 2012 | SOCIAL SCIENCES, BIOMEDICAL | SSCI | Q3 | — | 26/36 |
| 2011 | ETHICS | SSCI | Q2 | — | 22/47 |
| 2011 | SOCIAL ISSUES | SSCI | Q2 | — | 19/38 |
| 2011 | SOCIAL SCIENCES, BIOMEDICAL | SSCI | Q4 | — | 28/37 |
| 2010 | ETHICS | SSCI | Q3 | — | 27/39 |
| 2010 | SOCIAL ISSUES | SSCI | Q3 | — | 23/35 |
| 2010 | SOCIAL SCIENCES, BIOMEDICAL | SSCI | Q4 | — | 31/34 |
| 2009 | ETHICS | SSCI | Q2 | — | 17/34 |
| 2009 | SOCIAL ISSUES | SSCI | Q3 | — | 19/35 |
| 2009 | SOCIAL SCIENCES, BIOMEDICAL | SSCI | Q4 | — | 25/33 |
| 2008 | ETHICS | SSCI | Q2 | — | 14/28 |
| 2008 | SOCIAL ISSUES | SSCI | Q3 | — | 19/32 |
| 2008 | SOCIAL SCIENCES, BIOMEDICAL | SSCI | Q4 | — | 25/29 |
| 2007 | ETHICS | SSCI | Q2 | — | 12/28 |
| 2007 | SOCIAL ISSUES | SSCI | Q3 | — | 17/32 |
| 2007 | SOCIAL SCIENCES, BIOMEDICAL | SSCI | Q4 | — | 25/28 |
| 2006 | ETHICS | SSCI | Q2 | — | 13/28 |
| 2006 | SOCIAL ISSUES | SSCI | Q3 | — | 18/31 |
| 2006 | SOCIAL SCIENCES, BIOMEDICAL | SSCI | Q4 | — | 24/27 |
| 2005 | ETHICS | SSCI | Q2 | — | 11/29 |
| 2005 | SOCIAL ISSUES | SSCI | Q2 | — | 12/31 |
| 2005 | SOCIAL SCIENCES, BIOMEDICAL | SSCI | Q3 | — | 19/27 |
| 2004 | ETHICS | SSCI | Q3 | — | 18/28 |
| 2004 | SOCIAL ISSUES | SSCI | Q3 | — | 20/31 |
| 2004 | SOCIAL SCIENCES, BIOMEDICAL | SSCI | Q4 | — | 20/26 |
| 2003 | ETHICS | SSCI | Q3 | — | 21/28 |
| 2003 | SOCIAL ISSUES | SSCI | Q3 | — | 21/31 |
| 2003 | SOCIAL SCIENCES, BIOMEDICAL | SSCI | Q4 | — | 20/25 |
| 2002 | ETHICS | SSCI | Q4 | — | 23/28 |
| 2002 | SOCIAL ISSUES | SSCI | Q3 | — | 22/32 |
| 2002 | SOCIAL SCIENCES, BIOMEDICAL | SSCI | Q4 | — | 21/25 |
| 2001 | ETHICS | SSCI | Q2 | — | 14/30 |
| 2001 | SOCIAL ISSUES | SSCI | Q3 | — | 18/33 |
| 2001 | SOCIAL SCIENCES, BIOMEDICAL | SSCI | Q4 | — | 21/24 |
| 2000 | MEDICINE, LEGAL | SSCI | Q4 | — | 17/18 |
| 2000 | SOCIAL ISSUES | SSCI | Q2 | — | 17/34 |
| 2000 | SOCIAL SCIENCES, BIOMEDICAL | SSCI | Q4 | — | 16/20 |
| 1999 | MEDICINE, LEGAL | SSCI | Q4 | — | 19/19 |
| 1999 | SOCIAL ISSUES | SSCI | Q3 | — | 25/34 |
| 1999 | SOCIAL SCIENCES, BIOMEDICAL | SSCI | Q4 | — | 19/20 |